Atossa Genetics Revenue 2012-2024 | ATOS
Atossa Genetics revenue from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Atossa Genetics Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $0 |
| Atossa Genetics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.191B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $236.249B | 28.32 |
| Intuitive Surgical (ISRG) | United States | $174.454B | 98.78 |
| Alcon (ALC) | Switzerland | $48.446B | 34.10 |
| IQVIA Holdings (IQV) | United States | $43.260B | 24.51 |
| Edwards Lifesciences (EW) | United States | $41.114B | 26.35 |
| IDEXX Laboratories (IDXX) | United States | $40.351B | 48.54 |
| DexCom (DXCM) | United States | $27.438B | 39.13 |
| STERIS (STE) | Ireland | $23.871B | 27.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.249B | 0.00 |
| Waters (WAT) | United States | $19.395B | 28.91 |
| Hologic (HOLX) | United States | $18.584B | 20.20 |
| Sysmex ADR (SSMXY) | Japan | $12.248B | 38.41 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.053B | 13.51 |
| Teleflex (TFX) | United States | $11.522B | 17.91 |
| Globus Medical (GMED) | United States | $9.380B | 26.24 |
| Penumbra (PEN) | United States | $7.859B | 81.58 |
| Glaukos (GKOS) | United States | $6.896B | 0.00 |
| Masimo (MASI) | United States | $6.075B | 32.53 |
| TransMedics (TMDX) | United States | $4.797B | 205.44 |
| Integer Holdings (ITGR) | United States | $4.166B | 24.36 |
| PROCEPT BioRobotics (PRCT) | United States | $4.056B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.797B | 0.00 |
| Inari Medical (NARI) | United States | $2.626B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.576B | 15.11 |
| Nihon Kohden (NHNKY) | Japan | $2.424B | 15.09 |
| Elekta AB (EKTAY) | Sweden | $2.357B | 19.20 |
| Veracyte (VCYT) | United States | $2.329B | 144.38 |
| RxSight (RXST) | United States | $2.017B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.365B | 6.22 |
| Silk Road Medical (SILK) | United States | $1.107B | 0.00 |
| OPKO Health (OPK) | United States | $1.088B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.080B | 19.27 |
| Pulse Biosciences (PLSE) | United States | $1.051B | 0.00 |
| Artivion (AORT) | United States | $1.019B | 93.58 |
| Alphatec Holdings (ATEC) | United States | $0.766B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.755B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.664B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 16.33 |
| SiBone (SIBN) | United States | $0.629B | 0.00 |
| Paragon 28 (FNA) | United States | $0.623B | 0.00 |
| IRadimed (IRMD) | United States | $0.592B | 32.01 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.458B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.337B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.331B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.322B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.312B | 9.53 |
| AngioDynamics (ANGO) | United States | $0.299B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.277B | 0.00 |
| Inogen (INGN) | United States | $0.274B | 0.00 |
| NeuroPace (NPCE) | United States | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.176B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.166B | 11.64 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.135B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.120B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.096B | 14.34 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Envoy Medical (COCH) | United States | $0.062B | 0.00 |
| LENSAR (LNSR) | United States | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.040B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Neuronetics (STIM) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.022B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |